Physician profile
Serena E Mott
NPI 1184977506
$859.49
in general payments reported to CMS, 2019-2025
12 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $48.95 · 2022: $122 · 2023: $202 · 2024: $157 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $590 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.96 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $166.62 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Phathom Pharmaceuticals, INC. | $155.71 | 2024-2025 | Voquezna |
| Lilly USA, LLC | $140.17 | 2022-2023 | Mounjaro, Jardiance, Emgality |
| Janssen Biotech, INC. | $136.32 | 2025 | Tremfya, Stelara, Simponi |
| Pfizer INC. | $122.27 | 2021-2025 | |
| Glaxosmithkline, LLC. | $41.93 | 2022-2024 | Trelegy Ellipta, Arexvy |
| Exact Sciences Corporation | $18.83 | 2023 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $16.48 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $16.25 | 2025 | Simlandi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.67 | 2025 | Xifaxan |
| Medtronic, INC. | $15.40 | 2025 | Interstim |
| Abbott Laboratories | $13.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Serena Mott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.